• Almirall secures EIB grant to support research activities pharmaceutical-technology
    June 28, 2019
    The European Investment Bank (EIB) has granted a €120m loan to Spanish pharmaceutical company Almirall to support its research, development and innovation (RDI) activities related to skin healthcare therapeutic products.
PharmaSources Customer Service